Lu W, Gómez N, Lim J, Guha S, O Brien Jenkins A, Coffey E, et al. The P2Y12 Receptor Antagonist Ticagrelor Reduces Lysosomal pH and Autofluorescence in Retinal Pigmented Epithelial Cells From the ABCA4-/- Mouse Model of Retinal Degeneration. Front Pharmacol. 2018;9:242 pubmed publisher

Chan M, Leadbeater P, Watson S, Warner T. Not all light transmission aggregation assays are created equal: qualitative differences between light transmission and 96-well plate aggregometry. Platelets. 2018;29:686-689 pubmed publisher

Aungraheeta R, Conibear A, Butler M, Kelly E, Nylander S, Mumford A, et al. Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor. Blood. 2016;128:2717-2728 pubmed

Zhang J, Zhang K, Gao Z, Paoletta S, Zhang D, Han G, et al. Agonist-bound structure of the human P2Y12 receptor. Nature. 2014;509:119-22 pubmed publisher

Helms C, Marvel M, Zhao W, Stahle M, Vest R, Kato G, et al. Mechanisms of hemolysis-associated platelet activation. J Thromb Haemost. 2013;11:2148-54 pubmed publisher

Pinheiro A, Paramos de Carvalho D, Certal M, Costa C, Magalhães Cardoso M, Ferreirinha F, et al. Bradykinin-induced Ca2+ signaling in human subcutaneous fibroblasts involves ATP release via hemichannels leading to P2Y12 receptors activation. Cell Commun Signal. 2013;11:70 pubmed publisher

Gao Z, Wei Q, Jayasekara M, Jacobson K. The role of P2Y(14) and other P2Y receptors in degranulation of human LAD2 mast cells. Purinergic Signal. 2013;9:31-40 pubmed publisher